ICP-105 / InnoCare - LARVOL DELTA

Study of ICP-105 in Solid Tumors Patients (clinicaltrials.gov) - P1 | N=21 | Completed | Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. | Recruiting ➔ Completed | N=54 ➔ 21

Enrollment change • Trial completion • Oncology • Solid Tumor

Study of ICP-105 in Solid Tumors Patients (clinicaltrials.gov) - P1; N=54; Recruiting; Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.; Trial completion date: Jul 2021 ➔ Dec 2022; Trial primary completion date: Dec 2020 ➔ Dec 2022

Clinical • Trial completion date • Trial primary completion date • Oncology • Solid Tumor